Groundbreaking Implantable Wireless Heartfailure Device

Doctors of the USA welcomes William T. Abraham, MD, FACP, FACC, FAHA, FESC, director of the Division of Cardiovascular Medicine and a professor of internal medicine, physiology and cell biology at the Ohio State University Medical Center to talk about the first FDA approved wireless device with remote monitoring to measure pulmonary artery pressure in certain heart failure patients. Listen in as he shares about the safety and efficacy of the device and how it allows health care professionals to monitor the condition of their patients remotely.

Dr. William Abraham is the lead investigator for the CardioMEMS clinical trials and also serves as deputy director of Ohio State’s Dorothy M. Davis Heart and Lung Research Institute. He has been recognized as one of the “Best Doctors in America” for eight consecutive years. Also in 2009 he was named inaugural designated Chair of Excellence in Cardiovascular Medicine at Ohio State’s College of Medicine. Dr. Abraham earned his medical degree from Harvard Medical School in Boston, Mass., and completed his residency in internal medicine and fellowships in cardiology and heart failure/cardiac transplantation at the University of Colorado Health Sciences Center.

Dr. Abraham is an internationally known researcher in heart failure. He has received grants from the National Institutes of Health, the American College of Cardiology and the Aetna Quality Care Foundation and has participated as principal investigator in more than 100 multicenter clinical drug and device trials.In addition to authoring more than 600 original papers, abstracts, book chapters and review articles, Dr. Abraham also co-edited Heart Failure: A Practical Approach to Treatment, a leading textbook on heart failure.

Check out the Ohio State University Wexner Medical Center website.